140 related articles for article (PubMed ID: 12269698)
1. Comparative histological studies on liver of mice exposed to Cr(VI) and Cr(V) compounds.
das Neves RP; Santos TM; Pereira Mde L; de Jesus JP
Hum Exp Toxicol; 2002 Jul; 21(7):365-9. PubMed ID: 12269698
[TBL] [Abstract][Full Text] [Related]
2. Chromium(VI) induced alterations in mouse spleen cells: a short-term assay.
das Neves RP; Santos TM; de Pereira ML; de Jesus JP
Cytobios; 2001; 106 Suppl 1():27-34. PubMed ID: 11534826
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of a chromium(V) cis-dioxo bis(1,10-phenanthroline) complex and crystal and molecular structures of its chromium(III) precursor.
Weeks CL; Levina A; Dillon CT; Turner P; Fenton RR; Lay PA
Inorg Chem; 2004 Nov; 43(24):7844-56. PubMed ID: 15554650
[TBL] [Abstract][Full Text] [Related]
4. Formation and reactivity of chromium(V)-thiolato complexes: a model for the intracellular reactions of carcinogenic chromium(VI) with biological thiols.
Levina A; Zhang L; Lay PA
J Am Chem Soc; 2010 Jun; 132(25):8720-31. PubMed ID: 20527748
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes.
Wu LE; Levina A; Harris HH; Cai Z; Lai B; Vogt S; James DE; Lay PA
Angew Chem Int Ed Engl; 2016 Jan; 55(5):1742-5. PubMed ID: 26696553
[TBL] [Abstract][Full Text] [Related]
6. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
[TBL] [Abstract][Full Text] [Related]
7. In vivo reduction of chromium (VI) and its related free radical generation.
Liu KJ; Shi X
Mol Cell Biochem; 2001 Jun; 222(1-2):41-7. PubMed ID: 11678610
[TBL] [Abstract][Full Text] [Related]
8. Investigations on the nephrotoxicity and hepatotoxicity of trivalent and hexavalent chromium compounds.
Dartsch PC; Hildenbrand S; Kimmel R; Schmahl FW
Int Arch Occup Environ Health; 1998 Sep; 71 Suppl():S40-5. PubMed ID: 9827879
[TBL] [Abstract][Full Text] [Related]
9. Chromium (VI)-induced transformation is enhanced by Zn deficiency in BALB/c 3T3 cells.
Kimura T; Onodera A; Okumura F; Nakanishi T; Itoh N
J Toxicol Sci; 2015 Jun; 40(3):383-7. PubMed ID: 25972198
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis of lymphocytes in the presence of Cr(V) complexes: role in Cr(VI)-induced toxicity.
Vasant C; Balamurugan K; Rajaram R; Ramasami T
Biochem Biophys Res Commun; 2001 Aug; 285(5):1354-60. PubMed ID: 11478807
[TBL] [Abstract][Full Text] [Related]
11. Solution structures of chromium(VI) complexes with glutathione and model thiols.
Levina A; Lay PA
Inorg Chem; 2004 Jan; 43(1):324-35. PubMed ID: 14704084
[TBL] [Abstract][Full Text] [Related]
12. Redox and complexation chemistry of the Cr(VI)/Cr(V)/Cr(IV)-D-glucuronic acid system.
González JC; García S; Bellú S; Salas Peregrín JM; Atria AM; Sala LF; Signorella S
Dalton Trans; 2010 Mar; 39(9):2204-17. PubMed ID: 20162193
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopic characterization of genotoxic chromium(V) peptide complexes: Oxidation of Chromium(III) triglycine, tetraglycine and pentaglycine complexes.
Headlam HA; Lay PA
J Inorg Biochem; 2016 Sep; 162():227-237. PubMed ID: 27365280
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
15. Redox and complexation chemistry of the CrVI/CrV-D-glucaric acid system.
Mangiameli MF; González JC; Bellú S; Bertoni F; Sala LF
Dalton Trans; 2014 Jun; 43(24):9242-54. PubMed ID: 24816781
[TBL] [Abstract][Full Text] [Related]
16. Chromium(VI) interaction with plant and animal mitochondrial bioenergetics: a comparative study.
Fernandes MA; Santos MS; Alpoim MC; Madeira VM; Vicente JA
J Biochem Mol Toxicol; 2002; 16(2):53-63. PubMed ID: 11979422
[TBL] [Abstract][Full Text] [Related]
17. New insights on the mechanism of oxidation of D-galacturonic acid by hypervalent chromium.
Mangiameli MF; González JC; García SI; Frascaroli MI; Van Doorslaer S; Salas Peregrin JM; Sala LF
Dalton Trans; 2011 Jul; 40(26):7033-45. PubMed ID: 21629965
[TBL] [Abstract][Full Text] [Related]
18. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
Zhitkovich A; Quievryn G; Messer J; Motylevich Z
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization, and nuclease activity of biologically relevant chromium(V) complexes with monosaccharides and model diols. Likely intermediates in chromium-induced cancers.
Bartholomäus R; Irwin JA; Shi L; Smith SM; Levina A; Lay PA
Inorg Chem; 2013 Apr; 52(8):4282-92. PubMed ID: 23531300
[TBL] [Abstract][Full Text] [Related]
20. Eugenia dysenterica DC. (Myrtaceae) exerts chemopreventive effects against hexavalent chromium-induced damage in vitro and in vivo.
Ávila RI; Mattos Alvarenga CB; Ávila PH; Moreira RC; Arruda AF; Fernandes TO; Rodrigues BD; Andrade WM; Batista AC; Paula JR; Valadares MC
Pharm Biol; 2016 Nov; 54(11):2652-2663. PubMed ID: 27241623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
